Cargando…

Development of Crescentic Immunoglobulin A Nephritis and Multiple Autoantibodies in a Patient during Adalimumab Treatment for Rheumatoid Arthritis

Detalles Bibliográficos
Autores principales:	Li, Xia, Ma, Jie, Zhao, Yan, Wang, Hai-Yun, Li, Xue-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725558/ https://www.ncbi.nlm.nih.gov/pubmed/26365982 http://dx.doi.org/10.4103/0366-6999.164992

Ejemplares similares

Crescentic glomerular nephritis associated with rheumatoid arthritis: a case report
por: Balendran, K., et al.
Publicado: (2017)

The "Crescent" Dissecting Microscope
Publicado: (1924)

Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report
por: Omran, Narges E, et al.
Publicado: (2018)

Intravenous Tartar Emetic in Crescentic Malaria
por: Brodribb, C.
Publicado: (1917)

Significance of Crescentic Glomeruli in Acute Kidney Injury with Rheumatoid Arthritis
por: Ayaash, Ali, et al.
Publicado: (2019)

Tocilizumab Attenuates Anti-neutrophil Cytoplasmic Antibody-associated Nephritis Occurring during Abatacept and Adalimumab Therapy for Rheumatoid Arthritis
por: Yoshimura, Yusuke, et al.
Publicado: (2022)

Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
por: Gissel, C., et al.
Publicado: (2016)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca, Giuseppe, et al.
Publicado: (2013)

Adverse effects of maternal rheumatoid arthritis during pregnancy on children
por: Li, Rong, et al.
Publicado: (2021)

Lupus Cardiomyopathy and Nephritis Associated With Adalimumab and Cytomegalovirus Infection in a Patient With Seronegative Rheumatoid Arthritis: A Case of Rhupus Syndrome
por: Waitayangkoon, Palapun, et al.
Publicado: (2023)

A Case of Self-Limiting Crescentic Immunoglobulin A Glomerulonephritis Associated with Sternoclavicular Arthritis
por: Fujita, Yoko, et al.
Publicado: (2018)

Addition of Cyclosporine to Adalimumab Improved Psoriasis And Adalimumab-Induced Injection Site Reaction
por: Nakamizo, Satoshi, et al.
Publicado: (2014)

Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
por: Capsoni, Franco, et al.
Publicado: (2005)

Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
por: Zhao, Sizheng, et al.
Publicado: (2018)

Circulating Dickkof-1 as a potential biomarker associated with the prognosis of patients with rheumatoid arthritis-associated interstitial lung disease
por: Xue, Jing, et al.
Publicado: (2021)

Sweet’s Syndrome in a Patient With Seropositive Rheumatoid Arthritis After Starting Adalimumab: Is Sweet’s Syndrome Related to Rheumatoid Arthritis or Is It the Paradoxical Effect of Adalimumab?
por: Paul, Prodip, et al.
Publicado: (2021)

Co-existence of Rheumatoid Arthritis, Vitiligo, and Bullous Pemphigoid as Multiple Autoimmune Syndrome
por: Sundaram, Murugan, et al.
Publicado: (2014)

Remission of Subacute Psychosis in a COVID-19 Patient With an Antineuronal Autoantibody After Treatment With Intravenous Immunoglobulin
por: McAlpine, Lindsay S., et al.
Publicado: (2021)

Treatment of sarcoid granulomatous interstitial nephritis with adalimumab
por: Gupta, Roopali, et al.
Publicado: (2009)

Granulomatous interstitial nephritis secondary to adalimumab therapy
por: Sandys, Vicki, et al.
Publicado: (2018)

An unusual case of crescentic lupus nephritis presenting with normal renal function
por: Manohar, Sandhya, et al.
Publicado: (2015)

Treatment of membranous nephropathy with crescent nephritis by rituximab: A case report
por: Zhang, Fan, et al.
Publicado: (2022)

Autoantibodies in rheumatoid arthritis and their clinical significance
por: Steiner, Günter, et al.
Publicado: (2002)

New autoantibodies in early rheumatoid arthritis
por: Charpin, Caroline, et al.
Publicado: (2013)

Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
por: Burska, Agata N., et al.
Publicado: (2014)

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
por: Bugatti, Serena, et al.
Publicado: (2018)

The role of autoantibodies in the pathophysiology of rheumatoid arthritis
por: Derksen, V. F. A. M., et al.
Publicado: (2017)

Therapeutic implications of autoantibodies in rheumatoid arthritis
por: Aletaha, Daniel, et al.
Publicado: (2016)

Staphylococcal infection-associated crescentic immunoglobulin A nephropathy
por: Jung, Jong Hwan, et al.
Publicado: (2017)

Recurrent Crescentic Immunoglobulin A Nephropathy in the Graft Kidney
por: Bhargava, V.
Publicado: (2017)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab
por: Herenius, M M J, et al.
Publicado: (2011)

Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
por: Genovese, Mark C., et al.
Publicado: (2016)

Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis
por: Nguyen, Dao X., et al.
Publicado: (2018)

Adalimumab for treatment of very early onset inflammatory bowel disease
por: Xie, Yao, et al.
Publicado: (2019)

Ætiology of Nephritis
por: Birks, P. H.
Publicado: (1946)

Rheumatoid arthritis in the Kingdom of Saudi Arabia
por: Merashli, Mira, et al.
Publicado: (2015)

Clonal hematopoiesis in patients with rheumatoid arthritis
por: Savola, Paula, et al.
Publicado: (2018)

A Case of Adalimumab-Induced Granulomatous Interstitial Nephritis
por: Plant, Rory, et al.
Publicado: (2021)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hg0e0qes0ibjtd1leon26ovgco